$LOAN
MANHATTAN BRIDGE CAPITAL, INC

2015 Q2 Form 10-Q Financial Statement

#000114420415045344 Filed on July 31, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $912.0K $630.1K
YoY Change 44.74% 13.78%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $210.0K $180.0K
YoY Change 16.67% -10.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $210.0K $180.0K
YoY Change 16.67% -14.29%
Operating Profit $545.4K $331.1K
YoY Change 64.74% 34.02%
Interest Expense -$150.0K -$120.0K
YoY Change 25.0% 20.0%
% of Operating Profit -27.5% -36.24%
Other Income/Expense, Net $0.00 $10.00K
YoY Change -100.0% 0.0%
Pretax Income $530.4K $338.0K
YoY Change 56.95% 33.1%
Income Tax $0.00 -$83.00K
% Of Pretax Income 0.0% -24.56%
Net Earnings $530.4K $421.0K
YoY Change 26.0% 166.56%
Net Earnings / Revenue 58.17% 66.81%
Basic Earnings Per Share $0.08 $0.10
Diluted Earnings Per Share $0.08 $0.10
COMMON SHARES
Basic Shares Outstanding 6.471M shares 4.284M shares
Diluted Shares Outstanding 6.507M shares 4.323M shares

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.00K $140.0K
YoY Change -64.29% -87.16%
Cash & Equivalents $45.36K $135.5K
Short-Term Investments
Other Short-Term Assets $70.00K $50.00K
YoY Change 40.0% -2.16%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $15.27M $11.80M
YoY Change 29.41% -2.45%
LONG-TERM ASSETS
Property, Plant & Equipment $20.00K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $50.00K $210.0K
YoY Change -76.19% -16.0%
Other Assets $140.0K $204.4K
YoY Change -31.52% 922.15%
Total Long-Term Assets $11.27M $5.930M
YoY Change 90.05% 61.82%
TOTAL ASSETS
Total Short-Term Assets $15.27M $11.80M
Total Long-Term Assets $11.27M $5.930M
Total Assets $26.54M $17.73M
YoY Change 49.69% 12.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $90.00K $50.00K
YoY Change 80.0% 150.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.100M $1.320M
YoY Change -16.67% 13.85%
Long-Term Debt Due $6.990M $6.600M
YoY Change 5.91% 20.0%
Total Short-Term Liabilities $8.350M $8.274M
YoY Change 0.92% 17.56%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $8.350M $8.274M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $8.350M $8.270M
YoY Change 0.97% 17.47%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 177.0K shares 177.0K shares
Shareholders Equity $18.18M $9.460M
YoY Change
Total Liabilities & Shareholders Equity $26.54M $17.73M
YoY Change 49.69% 12.5%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income $530.4K $421.0K
YoY Change 26.0% 166.56%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities $480.0K $400.0K
YoY Change 20.0% 48.15%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$2.140M -$1.350M
YoY Change 58.52% -18.18%
Cash From Investing Activities -$2.150M -$1.350M
YoY Change 59.26% -18.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.240M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.450M 1.080M
YoY Change 34.26% -51.57%
NET CHANGE
Cash From Operating Activities 480.0K 400.0K
Cash From Investing Activities -2.150M -1.350M
Cash From Financing Activities 1.450M 1.080M
Net Change In Cash -220.0K 130.0K
YoY Change -269.23% -84.71%
FREE CASH FLOW
Cash From Operating Activities $480.0K $400.0K
Capital Expenditures $0.00
Free Cash Flow $480.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2015Q2 loan Share Based Compensation Expense
ShareBasedCompensationExpense
3416 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0959 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.595 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0171 pure
loan Fair Value Of Restricted Shares Amortization Period
FairValueOfRestrictedSharesAmortizationPeriod
P15Y
us-gaap Net Income Loss
NetIncomeLoss
629245 USD
us-gaap Net Income Loss
NetIncomeLoss
1006035 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
15460 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6832 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6832 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
28762 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
99892 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
31888 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
40987 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7651 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-76609 USD
loan Increase Decrease In Deferred Origination Fees
IncreaseDecreaseInDeferredOriginationFees
-42873 USD
loan Increase Decrease In Deferred Origination Fees
IncreaseDecreaseInDeferredOriginationFees
69327 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-242995 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
367654 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
759712 USD
loan Issuance Of Short Term Loans
IssuanceOfShortTermLoans
9764000 USD
loan Issuance Of Short Term Loans
IssuanceOfShortTermLoans
8825000 USD
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
7537983 USD
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
6950218 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2226017 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1875466 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
55230 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
24368 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
127966 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
973822 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
111400 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
972835 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1113439 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2315 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
135495 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Interest Paid
InterestPaid
318317 USD
us-gaap Depreciation
Depreciation
0 USD
us-gaap Depreciation
Depreciation
3200 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
204429 USD
CY2014Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
39221 shares
CY2015Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
36479 shares
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
1250000 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-2080234 USD
CY2015Q2 loan Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
50750 shares
CY2014Q3 loan Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
87719 shares
CY2015Q2 loan Warrants Exercise Price
WarrantsExercisePrice
5.4875
CY2014Q3 loan Warrants Exercise Price
WarrantsExercisePrice
3.5625
CY2015Q2 loan Warrants Expiry Date
WarrantsExpiryDate
2020-05-22
CY2014Q3 loan Warrants Expiry Date
WarrantsExpiryDate
2019-07-28
CY2015Q2 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
54928 USD
CY2014Q3 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
42224 USD
loan Interest Income From Loans
InterestIncomeFromLoans
1521079 USD
loan Interest Income From Loans
InterestIncomeFromLoans
1025436 USD
loan Origination Fees
OriginationFees
302636 USD
loan Origination Fees
OriginationFees
213556 USD
us-gaap Revenues
Revenues
1823715 USD
us-gaap Revenues
Revenues
1238992 USD
loan Interest And Amortization Of Debt Service Costs
InterestAndAmortizationOfDebtServiceCosts
333777 USD
loan Interest And Amortization Of Debt Service Costs
InterestAndAmortizationOfDebtServiceCosts
239329 USD
loan Referral Fees
ReferralFees
2312 USD
loan Referral Fees
ReferralFees
384 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
466591 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
351808 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
591521 USD
CY2015Q2 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
15000 USD
CY2014Q2 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
0 USD
us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
15000 USD
us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
0 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
337976 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
530439 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-83000 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
420976 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
530439 USD
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4283805 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6470905 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4323026 shares
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6507384 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6280278 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4270074 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6314909 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4303742 shares
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7394489 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6260689 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7217489 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6083689 shares
CY2015Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
177000 shares
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
177000 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
684 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4254527 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2013Q4 us-gaap Cost Method Investments
CostMethodInvestments
65000 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
34631 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
33668 shares
CY2015Q2 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
4920000 USD
CY2015Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4250000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
loan Share Based Compensation Expense
ShareBasedCompensationExpense
6832 USD
loan Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights For Employee And Nonemployee Directors
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsForEmployeeAndNonemployeeDirectors
The options may vest over a period not to exceed ten years. Stock options under our stock option plan may be awarded to officers, key-employees, consultants and non-employee directors of the Company. Under our stock option plan, generally each non-employee director of the Company is granted an option for 7,000 common shares upon first taking office, and through and including the fiscal year ended December 31, 2014, an annual option grant for an additional 7,000 common shares for each additional year in office.

Files In Submission

Name View Source Status
0001144204-15-045344-index-headers.html Edgar Link pending
0001144204-15-045344-index.html Edgar Link pending
0001144204-15-045344.txt Edgar Link pending
0001144204-15-045344-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
loan-20150630.xml Edgar Link completed
loan-20150630.xsd Edgar Link pending
loan-20150630_cal.xml Edgar Link unprocessable
loan-20150630_def.xml Edgar Link unprocessable
loan-20150630_lab.xml Edgar Link unprocessable
loan-20150630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v415765_10q.htm Edgar Link pending
v415765_ex31-1.htm Edgar Link pending
v415765_ex31-2.htm Edgar Link pending
v415765_ex32-1.htm Edgar Link pending
v415765_ex32-2.htm Edgar Link pending